![Neil Kumar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Kumar
Amministratore Delegato presso
EIDOS THERAPEUTICS, INC.
Patrimonio netto: 407 M $ in data 31/07/2026
Profilo
Fondatore di BridgeBio Pharma, Inc. e BridgeBio Pharma LLC, Neil Kumar ricopre la posizione di amministratore delegato e direttore di BridgeBio Pharma, Inc. e amministratore delegato e direttore di BridgeBio Pharma LLC e amministratore delegato di Eidos Therapeutics, Inc. (entrambe sono filiali di BridgeBio Pharma, Inc.). Neil Kumar è anche nel consiglio di PellePharm, Inc., Navire Pharma, Inc. e LianBio. Il Dr. Kumar è stato in precedenza Principale Associato alla McKinsey & Co., Inc., Principale alla Third Rock Ventures LLC e Vice Presidente dello sviluppo aziendale di MyoKardia, Inc. Ha conseguito una laurea e una laurea presso la Stanford University e un dottorato presso il Massachusetts Institute of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 5.077.460 ( 2,59% ) | 407 M $ | 31/07/2026 | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 27/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
LIANBIO -.--% | 10/04/2023 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Neil Kumar
| Società | Posizione | Inizio |
|---|---|---|
| LIANMEDICAL | Direttore/Membro del Consiglio | 01/10/2019 |
| EIDOS THERAPEUTICS, INC. | Amministratore Delegato | 01/03/2016 |
| BRIDGEBIO PHARMA, INC. | Fondatore | 01/01/2015 |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology Discovers and develops medicines for patients with genetic diseases | Fondatore | 01/01/2015 |
BridgeBio Chemistry, Inc. | Presidente | - |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Presidente | - |
Phoenix Tissue Repair, Inc.
 Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Presidente | - |
Calcilytix Therapeutics, Inc. | Presidente | - |
Adrenas Therapeutics, Inc. | Treasurer | - |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
Precedenti posizioni note di Neil Kumar
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Neil Kumar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
79
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology Discovers and develops medicines for patients with genetic diseases | Health Technology |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Phoenix Tissue Repair, Inc.
Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Adrenas Therapeutics, Inc. | |
BridgeBio Services, Inc.
 BridgeBio Services, Inc. Aerospace & DefenseElectronic Technology Part of BridgeBio Pharma, Inc., BridgeBio Services, Inc. is a company based in Palo Alto, CA. The CEO of the company is Neil Kumar. | Electronic Technology |
Calcilytix Therapeutics, Inc. | |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
BridgeBio Chemistry, Inc. |
